iSERA Lifesciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	May '26 May 29, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	652	464	219	22	0	12
Market Cap Growth	175064.29%	111.95%	917.05%	4951.17%	-96.41%	72.31%
Enterprise Value	640	480	221	23	0	31
Last Close Price	77.49	55.16	676.67	676.67	473.33	373.33
PE Ratio	104.72	178.81	157.45	-	-	-
PS Ratio	45.72	32.55	82.52	-	-	-
PB Ratio	7.90	5.62	-223.31	-9.95	-0.37	-263.13
P/TBV Ratio	7.90	5.62	-	-	-	-
EV/Sales Ratio	44.88	33.67	83.50	-	-	-
EV/EBIT Ratio	190.12	142.65	159.30	-	-	-
Debt / Equity Ratio	0.20	0.20	-16.38	-0.85	-1.08	-
Net Debt / Equity Ratio	-0.15	-0.15	-16.17	-0.85	-1.05	0.22
Net Debt / EBITDA Ratio	-	-	-	-	-	0.15
Net Debt / FCF Ratio	0.23	0.23	-1.13	-3.01	-0.99	0.00
Asset Turnover	0.24	0.24	0.33	-	-	-
Quick Ratio	6.24	6.24	7.22	0.02	0.07	0.18
Current Ratio	6.63	6.63	33.63	0.63	1.21	0.18
Return on Equity (ROE)	6.37%	6.37%	-	-	-	-
Return on Assets (ROA)	3.47%	3.47%	10.80%	-117.20%	-282.13%	-2.93%
Return on Invested Capital (ROIC)	6.07%	6.08%	19.13%	-	-185.14%	-27.12%
Return on Capital Employed (ROCE)	3.40%	3.40%	9.20%	311.70%	-1314.70%	2338.30%
Earnings Yield	0.40%	0.56%	0.64%	-4.38%	-262.36%	-8.89%
FCF Yield	-	-11.54%	-6.40%	-2.82%	-289.57%	-25.27%
Buyback Yield / Dilution	-994.50%	-994.50%	-6.76%	-0.09%	-	-